Coronavirus disease 2019 (COVID‐19) is a multisystemic disease that can cause progressive lung failure, organ dysfunction, and coagulation disorder associated with high mortality and morbidity. COVID‐19 is known to either primarily cause skin symptoms or increase existing skin diseases. Human papillomavirus (HPV) is a DNA virus that can cause benign and malignant neoplasms. Mucocutaneous verruca vulgaris are common benign lesions of HPV. Here, we report a case of verruca vulgaris regressed after COVID‐19.

No abstract

Vitiligo is a chronic skin disease that manifests itself as completely amelanotic, white, macules, and patches on any part of the body. Selective melanocyte apoptosis may result in irregular, progressive depigmented patches on the skin, mucosal membranes, and hair. Vitiligo is the most common cause of depigmentation on a global scale, with a prevalence of between 0.1% and 2% [1][2][3][4] .Vitiligo is a multifactorial, multigenic disease with complicated pathophysiology, including hereditary and non-genetic causes.Autoimmune, cytotoxic, oxidant-antioxidant, and neurological processes are implicated in melanocyte loss theories 5 . Although segmental and non-segmental vitiligo was formerly assumed to have independent etiologies, it has recently been shown that comparable inflammatory pathways may play a part in developing both forms 6 . Studies on sex hormones that may have a role in neuroendocrinological pathogenesis have been conducted. In their study, Hussein et al. discovered that male patients with adult vitiligo had

Background/aim Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder in which one experiences abdominal pain, tension, cramping, bloating, and changes in the form and frequency of defecation, without an underlying organic disease. Many skin diseases have been reported to be more common in people with functional bowel disease. To our knowledge, however, no previous study investigated the potential relationship between hidradenitis suppurativa (HS) and IBS. In this study, we aimed to examine the potential association between IBS and HS. Materials and methods Patients with HS and healthy subjects were enrolled in this cross-sectional study. All participants were assessed for the presence of IBS. ROME IV criteria were used to identify IBS cases. Hurley staging, modified Sartorius score, and physician’s global assessment score were applied to define clinical severity and staging of HS. Results According to the Rome IV diagnostic criteria, 54 (67.50%) of 80 HS patients and 23 (28.75%) of 80 control group were diagnosed with IBS. The frequency of IBS was statistically significantly higher in the patient group than in the control group (P < 0.001). No statistically significant difference was found between the two groups in terms of abnormal stool frequency and family history of IBS (P = 0.28, P = 0.862, respectively). Abnormal stool form, mucus in stool, abdominal distension, feeling of incomplete evacuation were statistically significantly higher in HS patients compared to the controls (P = 0.01, P = 0.02, P < 0.001, P = 0.001, respectively). Conclusion Our study revealed that there might be a potential link between HS and IBS.